Histalim
Histalim is a domain-linked entity (histalim.com) with no verifiable business activity documented in available sources — the domain resolves only to a Plesk default hosting placeholder and no products, customers, leadership, or operating footprint have been disclosed.
- Company typePrivate
- Founded2005
- HeadquartersMontpellier, France
- Headcount11–50
- GTM typeB2B
- OfferingServices
Histalim firmographics
Firmographics- Name
- Histalim
- Website
- https://histalim.com
- Company type
- Private
- Founded year
- 2005
- Headcount range
- 11–50 employees
- Short description
- Histalim is a domain-linked entity (histalim.com) with no verifiable business activity documented in available sources — the domain resolves only to a Plesk default hosting placeholder and no products, customers, leadership, or operating footprint have been disclosed.
- Ownership category
- akta.pro rank
Histalim industry classification
Industry- Product category
- Unknown
- akta.pro primary industry
- Pathology & Histopathology Services (HLAGAFAI)
Where Histalim is headquartered
LocationHeadquarters
- HQ city
- Montpellier
- HQ country
- France
- HQ region
- Europe
Markets served
Histalim business model
Business model- GTM type
- B2B
- Offering type
- Services
Histalim product offering
Product offeringCore offering
No substantive information about Histalim's core offerings is available. The company website (histalim.com) displays only a default Plesk web hosting placeholder page with no descriptions of products, services, or business activities.
Differentiator
Problem solved
Functional benefit
Histalim technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Histalim competitors and assessment
Company assessmentBroad incumbents
- Eurofins Scientific: International bioanalytical and preclinical testing group with histology and pathology service offerings through its pharma services segment. Comparable as a broad incumbent providing adjacent lab services to pharma/biotech.
- Crown Bioscience: Preclinical CRO focused on oncology and immuno-oncology models, with histology and biomarker services supporting translational research. Comparable as an incumbent serving similar pharma/biotech research customers.
- Charles River Laboratories: Large CRO with a broad preclinical services portfolio that includes histology, pathology, and toxicology. Relevant as a broad incumbent competitor that offers overlapping histopathology capability to pharma clients.
- Pharmaron: Global CRO/CDMO with preclinical histology, pathology, and DMPK service lines. Comparable as a broad incumbent offering overlapping preclinical lab services to biopharma.
- WuXi AppTec: Global preclinical and clinical CRO with significant histopathology, toxicology, and DMPK service lines. Comparable as a large incumbent that competes for outsourced preclinical histology work.
Direct peers
- HistoWiz: Specialty histopathology and digital pathology services provider for academic and biopharma clients. Directly comparable if Histalim operates as a histopathology services lab, given the identical core offering of tissue processing, staining, and slide digitization.
- IHC World: Specialty provider of immunohistochemistry, histology, and tissue services to research customers. Comparable as a direct peer if Histalim operates in research-grade histopathology services.
- Toxikon: Preclinical contract research organization with histology, pathology, and toxicology services for medical device and pharma clients. Comparable as a direct peer offering tissue-based preclinical services.
- Comparative Biosciences: Preclinical CRO offering histology and pathology evaluation alongside toxicology studies. Comparable as a direct peer offering histology services embedded in preclinical study packages.
Regional players
- Cerba Research: Europe-headquartered preclinical and clinical lab services provider with histopathology capability. Comparable as a regional peer serving European biopharma clients in similar histology services.
Market position
Customer concentration
Histalim social profiles
Digital presenceHistalim financial estimates
Financial estimateRevenue estimate
Valuation estimate
Histalim leadership team
Management profileNumber of profiles
Histalim funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Histalim M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Histalim
What does Histalim do?
No substantive information about Histalim's core offerings is available. The company website (histalim.com) displays only a default Plesk web hosting placeholder page with no descriptions of products, services, or business activities.
When was Histalim founded?
Histalim was founded in 2005. It employs 11 to 50 people.
Where is Histalim based?
Histalim is headquartered in Montpellier, France, in the Europe region.
Who are Histalim's main competitors?
Broad incumbents on record are Eurofins Scientific, Crown Bioscience, Charles River Laboratories, Pharmaron and WuXi AppTec. Direct peers are HistoWiz, IHC World, Toxikon and Comparative Biosciences. Cerba Research is listed as a regional player.
Does Histalim have an API?
No public API is recorded for Histalim.
What industry is Histalim in?
Histalim's product category is Unknown. Its primary akta.pro industry code is HLAGAFAI, Pathology & Histopathology Services.